Effects of intrauterine growth retardation and its subtypes on the development of the preterm infant

M A Martikainen1

  • 1Department of Paediatrics, Kuopio University Central Hospital, Finland.

Early Human Development
|January 1, 1992
PubMed

Insights

Preterm infants with intrauterine growth retardation (IUGR), particularly symmetric IUGR, face a higher risk of delayed neurological development. This impacts motor skills, speech, and social abilities, requiring closer monitoring.

Area of Science:

  • Neonatal neurology
  • Developmental pediatrics
  • Perinatal medicine

Background:

  • Intrauterine growth retardation (IUGR) affects fetal growth, potentially impacting long-term neurodevelopment.
  • Preterm infants are at increased risk for developmental issues, with IUGR potentially exacerbating these risks.

Purpose of the Study:

  • To investigate the neurological development of preterm infants with asymmetric (A-SGA) and symmetric (S-SGA) IUGR.
  • To compare developmental outcomes between SGA preterm infants, appropriate for gestational age (AGA) preterm infants, and full-term AGA infants.

Main Methods:

  • Prospective study comparing four groups: A-SGA preterm (n=26), S-SGA preterm (n=27), AGA preterm (n=131), and full-term AGA (n=121).
  • Neurological development assessed at 18 months corrected age using the modified Denver Developmental Screening Test.
  • Evaluated domains included fine and gross motor skills, visuo-auditory perception, speech, and social abilities.

Main Results:

  • Both A-SGA and S-SGA preterm groups showed higher rates of neurological abnormalities compared to controls.
  • A-SGA infants had lower visuo-auditory and social scores; S-SGA infants showed deficits across all domains except visuo-auditory perception.
  • IUGR and infant sex were significant predictors of slower neurological development.

Conclusions:

  • Preterm infants experiencing IUGR, especially the symmetric form, have a significantly increased likelihood of delayed neurological development.
  • These findings highlight the importance of monitoring neurodevelopmental trajectories in preterm infants with IUGR.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...